Glucoraphanin has the therapeutic potential of resolving hepatic steatosis in a murine model of diet-induced obesity
(IDF2021 2021)
抗凝固薬エドキサバンの時間薬理学的検討
(第42回日本臨床薬理学会学術総会 2021)
抗凝固薬エドキサバンの時間薬理学的検討
(第26回日本時間生物学会 2019)
Nrf2 activation by glucoraphanin alleviates high-fat diet-induced obesity and insulin resistance through adipose tissue browning.
(Environmental Response V 2019)